Apple (AAPL) 10-Q 1 Aug 24 2024 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares shares in Thousands	9 Months Ended
	Jun. 29, 2024	Jul. 19, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 29, 2024
Document Transition Report	false
Entity File Number	001-36743
Entity Registrant Name	Apple Inc.
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	94-2404110
Entity Address, Address Line One	One Apple Park Way
Entity Address, City or Town	Cupertino
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95014
City Area Code	408
Local Phone Number	996-1010
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		15,204,137
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000320193
Current Fiscal Year End Date	--09-28
Common Stock, $0.00001 par value per share
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $0.00001 par value per share
Trading Symbol	AAPL
Security Exchange Name	NASDAQ
0.000% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.000% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.875% Notes due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.625% Notes due 2026
Entity Information [Line Items]
Title of 12(b) Security	1.625% Notes due 2026
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
2.000% Notes due 2027
Entity Information [Line Items]
Title of 12(b) Security	2.000% Notes due 2027
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
1.375% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.375% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.050% Notes due 2029
Entity Information [Line Items]
Title of 12(b) Security	3.050% Notes due 2029
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
0.500% Notes due 2031
Entity Information [Line Items]
Title of 12(b) Security	0.500% Notes due 2031
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ
3.600% Notes due 2042
Entity Information [Line Items]
Title of 12(b) Security	3.600% Notes due 2042
No Trading Symbol Flag	true
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Net sales	$ 85,777	$ 81,797	$ 296,105	$ 293,787
Cost of sales	46,099	45,384	159,301	165,066
Gross margin	39,678	36,413	136,804	128,721
Operating expenses:
Research and development	8,006	7,442	23,605	22,608
Selling, general and administrative	6,320	5,973	19,574	18,781
Total operating expenses	14,326	13,415	43,179	41,389
Operating income	25,352	22,998	93,625	87,332
Other income/(expense), net	142	(265)	250	(594)
Income before provision for income taxes	25,494	22,733	93,875	86,738
Provision for income taxes	4,046	2,852	14,875	12,699
Net income	$ 21,448	$ 19,881	$ 79,000	$ 74,039
Earnings per share:
Basic (in dollars per share)	$ 1.40	$ 1.27	$ 5.13	$ 4.69
Diluted (in dollars per share)	$ 1.40	$ 1.26	$ 5.11	$ 4.67
Shares used in computing earnings per share:
Basic (in shares)	15,287,521	15,697,614	15,401,047	15,792,497
Diluted (in shares)	15,348,175	15,775,021	15,463,175	15,859,263
Products
Net sales	$ 61,564	$ 60,584	$ 224,908	$ 230,901
Cost of sales	39,803	39,136	140,667	146,696
Services
Net sales	24,213	21,213	71,197	62,886
Cost of sales	$ 6,296	$ 6,248	$ 18,634	$ 18,370

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 21,448	$ 19,881	$ 79,000	$ 74,039
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax	(73)	(385)	(87)	(494)
Change in unrealized gains/losses on derivative instruments, net of tax:
Change in fair value of derivative instruments	406	509	331	(492)
Adjustment for net (gains)/losses realized and included in net income	(87)	103	(678)	(1,854)
Total change in unrealized gains/losses on derivative instruments	319	612	(347)	(2,346)
Change in unrealized gains/losses on marketable debt securities, net of tax:
Change in fair value of marketable debt securities	268	(340)	3,306	1,963
Adjustment for net (gains)/losses realized and included in net income	30	58	164	185
Total change in unrealized gains/losses on marketable debt securities	298	(282)	3,470	2,148
Total other comprehensive income/(loss)	544	(55)	3,036	(692)
Total comprehensive income	$ 21,992	$ 19,826	$ 82,036	$ 73,347

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) shares in Thousands, $ in Millions	Jun. 29, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 25,565	$ 29,965
Marketable securities	36,236	31,590
Accounts receivable, net	22,795	29,508
Vendor non-trade receivables	20,377	31,477
Inventories	6,165	6,331
Other current assets	14,297	14,695
Total current assets	125,435	143,566
Non-current assets:
Marketable securities	91,240	100,544
Property, plant and equipment, net	44,502	43,715
Other non-current assets	70,435	64,758
Total non-current assets	206,177	209,017
Total assets	331,612	352,583
Current liabilities:
Accounts payable	47,574	62,611
Other current liabilities	60,889	58,829
Deferred revenue	8,053	8,061
Commercial paper	2,994	5,985
Term debt	12,114	9,822
Total current liabilities	131,624	145,308
Non-current liabilities:
Term debt	86,196	95,281
Other non-current liabilities	47,084	49,848
Total non-current liabilities	133,280	145,129
Total liabilities	264,904	290,437
Commitments and contingencies
Common stock, shares outstanding (in shares)	15,222,259	15,550,061
Common stock, shares issued (in shares)	15,222,259	15,550,061
Shareholders’ equity:
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,222,259 and 15,550,061 shares issued and outstanding, respectively	$ 79,850	$ 73,812
Accumulated deficit	(4,726)	(214)
Accumulated other comprehensive loss	(8,416)	(11,452)
Total shareholders’ equity	66,708	62,146
Total liabilities and shareholders’ equity	$ 331,612	$ 352,583

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Jun. 29, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	50,400,000,000	50,400,000,000
Common stock, shares issued (in shares)	15,222,259,000	15,550,061,000
Common stock, shares outstanding (in shares)	15,222,259,000	15,550,061,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common stock and additional paid-in capital	Retained earnings/(Accumulated deficit)	Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 24, 2022	$ 50,672	$ 64,849	$ (3,068)	$ (11,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		690
Common stock withheld related to net share settlement of equity awards		(3,310)	(1,988)
Share-based compensation		8,438
Net income	74,039		74,039
Dividends and dividend equivalents declared			(11,207)
Common stock repurchased			(56,368)
Other comprehensive income/(loss)	(692)			(692)
Ending balances at Jul. 01, 2023	$ 60,274	70,667	1,408	(11,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.70
Beginning balances at Apr. 01, 2023	$ 62,158	69,568	4,336	(11,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		0
Common stock withheld related to net share settlement of equity awards		(1,595)	(858)
Share-based compensation		2,694
Net income	19,881		19,881
Dividends and dividend equivalents declared			(3,811)
Common stock repurchased			(18,140)
Other comprehensive income/(loss)	(55)			(55)
Ending balances at Jul. 01, 2023	$ 60,274	70,667	1,408	(11,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.24
Beginning balances at Sep. 30, 2023	$ 62,146	73,812	(214)	(11,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		752
Common stock withheld related to net share settlement of equity awards		(3,802)	(1,517)
Share-based compensation		9,088
Net income	79,000		79,000
Dividends and dividend equivalents declared			(11,384)
Common stock repurchased	(70,000)		(70,611)
Other comprehensive income/(loss)	3,036			3,036
Ending balances at Jun. 29, 2024	$ 66,708	79,850	(4,726)	(8,416)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.73
Beginning balances at Mar. 30, 2024	$ 74,194	78,815	4,339	(8,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued		0
Common stock withheld related to net share settlement of equity awards		(1,920)	(428)
Share-based compensation		2,955
Net income	21,448		21,448
Dividends and dividend equivalents declared			(3,864)
Common stock repurchased			(26,221)
Other comprehensive income/(loss)	544			544
Ending balances at Jun. 29, 2024	$ 66,708	$ 79,850	$ (4,726)	$ (8,416)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)	$ 0.25

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023
Statement of Cash Flows [Abstract]
Cash, cash equivalents and restricted cash, beginning balances	$ 30,737	$ 24,977
Operating activities:
Net income	79,000	74,039
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization	8,534	8,866
Share-based compensation expense	8,830	8,208
Other	(1,964)	(1,651)
Changes in operating assets and liabilities:
Accounts receivable, net	6,697	7,609
Vendor non-trade receivables	11,100	13,111
Inventories	41	(2,570)
Other current and non-current assets	(5,626)	(4,863)
Accounts payable	(15,171)	(16,790)
Other current and non-current liabilities	2	2,986
Cash generated by operating activities	91,443	88,945
Investing activities:
Purchases of marketable securities	(38,074)	(20,956)
Proceeds from maturities of marketable securities	39,838	27,857
Proceeds from sales of marketable securities	7,382	3,959
Payments for acquisition of property, plant and equipment	(6,539)	(8,796)
Other	(1,117)	(753)
Cash generated by investing activities	1,490	1,311
Financing activities:
Payments for taxes related to net share settlement of equity awards	(5,163)	(5,119)
Payments for dividends and dividend equivalents	(11,430)	(11,267)
Repurchases of common stock	(69,866)	(56,547)
Proceeds from issuance of term debt, net	0	5,228
Repayments of term debt	(7,400)	(11,151)
Repayments of commercial paper, net	(2,985)	(5,971)
Other	(191)	(508)
Cash used in financing activities	(97,035)	(85,335)
Increase/(Decrease) in cash, cash equivalents and restricted cash	(4,102)	4,921
Cash, cash equivalents and restricted cash, ending balances	26,635	29,898
Supplemental cash flow disclosure:
Cash paid for income taxes, net	$ 19,230	$ 7,020

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Jun. 29, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Form 10-K”). The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.

Revenue

Revenue	9 Months Ended
	Jun. 29, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Net sales disaggregated by significant products and services for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 were as follows (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, iPhone ® $ 39,296 $ 39,669 $ 154,961 $ 156,778 Mac ® 7,009 6,840 22,240 21,743 iPad ® 7,162 5,791 19,744 21,857 Wearables, Home and Accessories 8,097 8,284 27,963 30,523 Services 24,213 21,213 71,197 62,886 Total net sales $ 85,777 $ 81,797 $ 296,105 $ 293,787 Total net sales include $3.4 billion of revenue recognized in the three months ended June 29, 2024 that was included in deferred revenue as of March 30, 2024, $3.3 billion of revenue recognized in the three months ended July 1, 2023 that was included in deferred revenue as of April 1, 2023 , $6.5 billion of revenue recognized in the nine months ended June 29, 2024 that was included in deferred revenue as of September 30, 2023, and $7.0 billion of revenue recognized in the nine months ended July 1, 2023 that was included in deferred revenue as of September 24, 2022. The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 11, “Segment Information and Geographic Data” for the three- and nine-month periods ended June 29, 2024 and July 1, 2023, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales. As of June 29, 2024 and September 30, 2023, the Company had total deferred revenue of $12.5 billion and $12.1 billion, respectively. As of June 29, 2024, the Company expects 64% of total deferred revenue to be realized in less than a year, 25% within one-to-two years, 9% within two-to-three years and 2% in greater than three years.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jun. 29, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table shows the computation of basic and diluted earnings per share for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (net income in millions and shares in thousands): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Numerator: Net income $ 21,448 $ 19,881 $ 79,000 $ 74,039 Denominator: Weighted-average basic shares outstanding 15,287,521 15,697,614 15,401,047 15,792,497 Effect of dilutive share-based awards 60,654 77,407 62,128 66,766 Weighted-average diluted shares 15,348,175 15,775,021 15,463,175 15,859,263 Basic earnings per share $ 1.40 $ 1.27 $ 5.13 $ 4.69 Diluted earnings per share $ 1.40 $ 1.26 $ 5.11 $ 4.67 Approximately 32 million restricted stock units (“RSUs”) were excluded from the computation of diluted earnings per share for the nine months ended July 1, 2023 because their effect would have been antidilutive.

Financial Instruments

Financial Instruments	9 Months Ended
	Jun. 29, 2024
Financial Instruments [Abstract]
Financial Instruments	Financial Instruments Cash, Cash Equivalents and Marketable Securities The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of June 29, 2024 and September 30, 2023 (in millions): June 29, 2024 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 22,866 $ — $ — $ 22,866 $ 22,866 $ — $ — Level 1: Money market funds 1,648 — — 1,648 1,648 — — Mutual funds 493 76 (7) 562 — 562 — Subtotal 2,141 76 (7) 2,210 1,648 562 — Level 2 (1) : U.S. Treasury securities 16,298 3 (855) 15,446 138 4,649 10,659 U.S. agency securities 5,500 — (418) 5,082 73 518 4,491 Non-U.S. government securities 17,560 31 (680) 16,911 — 11,592 5,319 Certificates of deposit and time deposits 1,337 — — 1,337 838 492 7 Commercial paper 1,346 — — 1,346 2 1,344 — Corporate debt securities 68,194 83 (3,350) 64,927 — 15,489 49,438 Municipal securities 480 — (13) 467 — 197 270 Mortgage- and asset-backed securities 24,508 27 (2,086) 22,449 — 1,393 21,056 Subtotal 135,223 144 (7,402) 127,965 1,051 35,674 91,240 Total (2) $ 160,230 $ 220 $ (7,409) $ 153,041 $ 25,565 $ 36,236 $ 91,240 September 30, 2023 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 28,359 $ — $ — $ 28,359 $ 28,359 $ — $ — Level 1: Money market funds 481 — — 481 481 — — Mutual funds and equity securities 442 12 (26) 428 — 428 — Subtotal 923 12 (26) 909 481 428 — Level 2 (1) : U.S. Treasury securities 19,406 — (1,292) 18,114 35 5,468 12,611 U.S. agency securities 5,736 — (600) 5,136 36 271 4,829 Non-U.S. government securities 17,533 6 (1,048) 16,491 — 11,332 5,159 Certificates of deposit and time deposits 1,354 — — 1,354 1,034 320 — Commercial paper 608 — — 608 — 608 — Corporate debt securities 76,840 6 (5,956) 70,890 20 12,627 58,243 Municipal securities 628 — (26) 602 — 192 410 Mortgage- and asset-backed securities 22,365 6 (2,735) 19,636 — 344 19,292 Subtotal 144,470 18 (11,657) 132,831 1,125 31,162 100,544 Total (2) $ 173,752 $ 30 $ (11,683) $ 162,099 $ 29,965 $ 31,590 $ 100,544 (1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. (2) As of June 29, 2024 and September 30, 2023, total marketable securities included $14.1 billion and $13.8 billion, respectively, that were restricted from general use, related to the State Aid Decision (refer to Note 6, “Income Taxes”) and other agreements. The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of June 29, 2024 (in millions): Due after 1 year through 5 years $ 64,209 Due after 5 years through 10 years 8,660 Due after 10 years 18,371 Total fair value $ 91,240 Derivative Instruments and Hedging The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates. Foreign Exchange Rate Risk To protect gross margins from fluctuations in foreign exchange rates, the Company may use forwards, options or other instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign exchange rates, the Company may use forwards, cross-currency swaps or other instruments. The Company designates these instruments as either cash flow or fair value hedges. As of June 29, 2024, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for term debt–related foreign currency transactions is 18 years. The Company may also use derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign exchange rates, as well as to offset a portion of the foreign currency gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies. Interest Rate Risk To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may use interest rate swaps, options or other instruments. The Company designates these instruments as either cash flow or fair value hedges. The notional amounts of the Company’s outstanding derivative instruments as of June 29, 2024 and September 30, 2023 were as follows (in millions): June 29, September 30, Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 65,542 $ 74,730 Interest rate contracts $ 13,875 $ 19,375 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 97,136 $ 104,777 The carrying amounts of the Company’s hedged items in fair value hedges as of June 29, 2024 and September 30, 2023 were as follows (in millions): June 29, September 30, Hedged assets/(liabilities): Current and non-current marketable securities $ 15,007 $ 14,433 Current and non-current term debt $ (13,096) $ (18,247) Accounts Receivable Trade Receivables The Company’s third-party cellular network carriers accounted for 32% and 41% of total trade receivables as of June 29, 2024 and September 30, 2023, respectively. The Company requires third-party credit support or collateral from certain customers to limit credit risk. Vendor Non-Trade Receivables The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in products net sales. Rather, the Company recognizes any gain on these sales as a reduction of products cost of sales when the related final products are sold by the Company. As of June 29, 2024, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted f or 46% and 18% . A s of September 30, 2023, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 48% and 23%.

Condensed Consolidated Financia

Condensed Consolidated Financial Statement Details	9 Months Ended
	Jun. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Financial Statement Details	Condensed Consolidated Financial Statement Details The following table shows the Company’s condensed consolidated financial statement details as of June 29, 2024 and September 30, 2023 (in millions): Property, Plant and Equipment, Net June 29, September 30, Gross property, plant and equipment $ 117,129 $ 114,599 Accumulated depreciation (72,627) (70,884) Total property, plant and equipment, net $ 44,502 $ 43,715

Income Taxes

Income Taxes	9 Months Ended
	Jun. 29, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes European Commission State Aid Decision On August 30, 2016, the European Commission (the “Commission”) announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (the “State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward. The Company and Ireland appealed the State Aid Decision to the General Court of the Court of Justice of the European Union (the “General Court”). On July 15, 2020, the General Court annulled the State Aid Decision. On September 25, 2020, the Commission appealed the General Court’s decision to the European Court of Justice (the “ECJ”) and a hearing was held on May 23, 2023. A decision from the ECJ is expected in the fourth quarter of 2024. The Company believes it would be eligible to claim a U.S. foreign tax credit for a portion of any incremental Irish corporate income taxes potentially due related to the State Aid Decision.

Debt

Debt	9 Months Ended
	Jun. 29, 2024
Debt Disclosure [Abstract]
Debt	Debt Commercial Paper The Company issues unsecured short-term promissory notes pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of June 29, 2024 and September 30, 2023, the Company had $3.0 billion and $6.0 billion of commercial paper outstanding, respectively. The following table provides a summary of cash flows associated with the issuance and maturities of commercial paper for the nine months ended June 29, 2024 and July 1, 2023 (in millions): Nine Months Ended June 29, July 1, Maturities 90 days or less: Repayments of commercial paper, net $ (2,985) $ (3,326) Maturities greater than 90 days: Repayments of commercial paper — (2,645) Total repayments of commercial paper, net $ (2,985) $ (5,971) Term Debt As of June 29, 2024 and September 30, 2023, the Company had outstanding fixed-rate notes with varying maturities for an aggregate carrying amount of $98.3 billion and $105.1 billion, respectively (collectively the “Notes”). As of June 29, 2024 and September 30, 2023, the fair value of the Company’s Notes, based on Level 2 inputs, was $86.2 billion and $90.8 billion, respectively.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Jun. 29, 2024
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Share Repurchase Program During the nine months ended June 29, 2024, the Company repurchased 387 million shares of its common stock for $70.0 billion. The Company’s share repurchase programs do not obligate the Company to acquire a minimum amount of shares. Under the programs, shares may be repurchased in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Jun. 29, 2024
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Restricted Stock Units A summary of the Company’s RSU activity and related information for the nine months ended June 29, 2024 is as follows: Number of RSUs (in thousands) Weighted-Average Aggregate Fair Value (in millions) Balance as of September 30, 2023 180,247 $ 135.91 RSUs granted 78,276 $ 172.26 RSUs vested (83,842) $ 126.47 RSUs canceled (8,258) $ 137.85 Balance as of June 29, 2024 166,423 $ 157.66 $ 35,052 The fair value as of the respective vesting dates of RSUs was $6.4 billion an d $15.0 billion for the three- and nine-month periods ended June 29, 2024, respectively, and was $7.0 billion and $14.9 billion for the three- and nine-month periods ended July 1, 2023, respectively. Share-Based Compensation The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Share-based compensation expense $ 2,869 $ 2,617 $ 8,830 $ 8,208 Income tax benefit related to share-based compensation expense $ (764) $ (993) $ (2,662) $ (2,791) As of June 29, 2024, the total unrecognized compensation cost related to outstanding RSUs was $21.9 billion, which the Company expects to recognize over a weighted-average period of 2.6 years.

Contingencies

Contingencies	9 Months Ended
	Jun. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.

Segment Information and Geograp

Segment Information and Geographic Data	9 Months Ended
	Jun. 29, 2024
Segment Reporting [Abstract]
Segment Information and Geographic Data	Segment Information and Geographic Data The following table shows information by reportable segment for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Americas: Net sales $ 37,678 $ 35,383 $ 125,381 $ 122,445 Operating income $ 15,209 $ 13,117 $ 50,640 $ 44,908 Europe: Net sales $ 21,884 $ 20,205 $ 76,404 $ 71,831 Operating income $ 9,170 $ 7,995 $ 31,872 $ 27,380 Greater China: Net sales $ 14,728 $ 15,758 $ 51,919 $ 57,475 Operating income $ 5,562 $ 6,207 $ 20,884 $ 24,175 Japan: Net sales $ 5,097 $ 4,821 $ 19,126 $ 18,752 Operating income $ 2,544 $ 2,443 $ 9,498 $ 9,073 Rest of Asia Pacific: Net sales $ 6,390 $ 5,630 $ 23,275 $ 23,284 Operating income $ 2,610 $ 2,328 $ 9,995 $ 9,447 A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 is as follows (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Segment operating income $ 35,095 $ 32,090 $ 122,889 $ 114,983 Research and development expense (8,006) (7,442) (23,605) (22,608) Other corporate expenses, net (1,737) (1,650) (5,659) (5,043) Total operating income $ 25,352 $ 22,998 $ 93,625 $ 87,332

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Pay vs Performance Disclosure
Net income	$ 21,448	$ 19,881	$ 79,000	$ 74,039

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 29, 2024
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Tim Cook [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On May 24, 2024, Tim Cook, the Company’s Chief Executive Officer, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the sale, subject to certain price limits, of shares vesting during the duration of the plan pursuant to certain equity awards granted to Mr. Cook, excluding shares withheld by the Company to satisfy income tax withholding and remittance obligations. Mr. Cook’s plan will expire on May 24, 2026, subject to early termination in accordance with the terms of the plan.
Name	Tim Cook
Title	Chief Executive Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 24, 2024
Arrangement Duration	730 days

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Jun. 29, 2024
Accounting Policies [Abstract]
Basis of Presentation and Preparation	Basis of Presentation and Preparation The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles (“GAAP”) requires the use of management estimates. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 (the “2023 Form 10-K”).
Fiscal Period	The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Fair Value Measurements	The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Jun. 29, 2024
Revenue from Contract with Customer [Abstract]
Net Sales Disaggregated by Significant Products and Services	Net sales disaggregated by significant products and services for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 were as follows (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, iPhone ® $ 39,296 $ 39,669 $ 154,961 $ 156,778 Mac ® 7,009 6,840 22,240 21,743 iPad ® 7,162 5,791 19,744 21,857 Wearables, Home and Accessories 8,097 8,284 27,963 30,523 Services 24,213 21,213 71,197 62,886 Total net sales $ 85,777 $ 81,797 $ 296,105 $ 293,787

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Jun. 29, 2024
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table shows the computation of basic and diluted earnings per share for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (net income in millions and shares in thousands): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Numerator: Net income $ 21,448 $ 19,881 $ 79,000 $ 74,039 Denominator: Weighted-average basic shares outstanding 15,287,521 15,697,614 15,401,047 15,792,497 Effect of dilutive share-based awards 60,654 77,407 62,128 66,766 Weighted-average diluted shares 15,348,175 15,775,021 15,463,175 15,859,263 Basic earnings per share $ 1.40 $ 1.27 $ 5.13 $ 4.69 Diluted earnings per share $ 1.40 $ 1.26 $ 5.11 $ 4.67

Financial Instruments (Tables)

Financial Instruments (Tables)	9 Months Ended
	Jun. 29, 2024
Financial Instruments [Abstract]
Cash, Cash Equivalents and Marketable Securities by Significant Investment Category	The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of June 29, 2024 and September 30, 2023 (in millions): June 29, 2024 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Marketable Cash $ 22,866 $ — $ — $ 22,866 $ 22,866 $ — $ — Level 1: Money market funds 1,648 — — 1,648 1,648 — — Mutual funds 493 76 (7) 562 — 562 — Subtotal 2,141 76 (7) 2,210 1,648 562 — Level 2 (1) : U.S. Treasury securities 16,298 3 (855) 15,446 138 4,649 10,659 U.S. agency securities 5,500 — (418) 5,082 73 518 4,491 Non-U.S. government securities 17,560 31 (680) 16,911 — 11,592 5,319 Certificates of deposit and time deposits 1,337 — — 1,337 838 492 7 Commercial paper 1,346 — — 1,346 2 1,344 — Corporate debt securities 68,194 83 (3,350) 64,927 — 15,489 49,438 Municipal securities 480 — (13) 467 — 197 270 Mortgage- and asset-backed securities 24,508 27 (2,086) 22,449 — 1,393 21,056 Subtotal 135,223 144 (7,402) 127,965 1,051 35,674 91,240 Total (2) $ 160,230 $ 220 $ (7,409) $ 153,041 $ 25,565 $ 36,236 $ 91,240 September 30, 2023 Adjusted Unrealized Unrealized Fair Cash and Current Non-Current Cash $ 28,359 $ — $ — $ 28,359 $ 28,359 $ — $ — Level 1: Money market funds 481 — — 481 481 — — Mutual funds and equity securities 442 12 (26) 428 — 428 — Subtotal 923 12 (26) 909 481 428 — Level 2 (1) : U.S. Treasury securities 19,406 — (1,292) 18,114 35 5,468 12,611 U.S. agency securities 5,736 — (600) 5,136 36 271 4,829 Non-U.S. government securities 17,533 6 (1,048) 16,491 — 11,332 5,159 Certificates of deposit and time deposits 1,354 — — 1,354 1,034 320 — Commercial paper 608 — — 608 — 608 — Corporate debt securities 76,840 6 (5,956) 70,890 20 12,627 58,243 Municipal securities 628 — (26) 602 — 192 410 Mortgage- and asset-backed securities 22,365 6 (2,735) 19,636 — 344 19,292 Subtotal 144,470 18 (11,657) 132,831 1,125 31,162 100,544 Total (2) $ 173,752 $ 30 $ (11,683) $ 162,099 $ 29,965 $ 31,590 $ 100,544 (1) The valuation techniques used to measure the fair values of the Company’s Level 2 financial instruments, which generally have counterparties with high credit ratings, are based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. (2) As of June 29, 2024 and September 30, 2023, total marketable securities included $14.1 billion and $13.8 billion, respectively, that were restricted from general use, related to the State Aid Decision (refer to Note 6, “Income Taxes”) and other agreements.
Non-Current Marketable Debt Securities by Contractual Maturity	The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of June 29, 2024 (in millions): Due after 1 year through 5 years $ 64,209 Due after 5 years through 10 years 8,660 Due after 10 years 18,371 Total fair value $ 91,240
Notional Amounts of Outstanding Derivative Instruments	The notional amounts of the Company’s outstanding derivative instruments as of June 29, 2024 and September 30, 2023 were as follows (in millions): June 29, September 30, Derivative instruments designated as accounting hedges: Foreign exchange contracts $ 65,542 $ 74,730 Interest rate contracts $ 13,875 $ 19,375 Derivative instruments not designated as accounting hedges: Foreign exchange contracts $ 97,136 $ 104,777
Carrying Amounts of Hedged Items in Fair Value Hedges	The carrying amounts of the Company’s hedged items in fair value hedges as of June 29, 2024 and September 30, 2023 were as follows (in millions): June 29, September 30, Hedged assets/(liabilities): Current and non-current marketable securities $ 15,007 $ 14,433 Current and non-current term debt $ (13,096) $ (18,247)

Condensed Consolidated Financ_2

Condensed Consolidated Financial Statement Details (Tables)	9 Months Ended
	Jun. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property, Plant and Equipment, Net	The following table shows the Company’s condensed consolidated financial statement details as of June 29, 2024 and September 30, 2023 (in millions): Property, Plant and Equipment, Net June 29, September 30, Gross property, plant and equipment $ 117,129 $ 114,599 Accumulated depreciation (72,627) (70,884) Total property, plant and equipment, net $ 44,502 $ 43,715

Debt (Tables)

Debt (Tables)	9 Months Ended
	Jun. 29, 2024
Debt Disclosure [Abstract]
Summary of Cash Flows Associated with the Issuance and Maturities of Commercial Paper	The following table provides a summary of cash flows associated with the issuance and maturities of commercial paper for the nine months ended June 29, 2024 and July 1, 2023 (in millions): Nine Months Ended June 29, July 1, Maturities 90 days or less: Repayments of commercial paper, net $ (2,985) $ (3,326) Maturities greater than 90 days: Repayments of commercial paper — (2,645) Total repayments of commercial paper, net $ (2,985) $ (5,971)

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Jun. 29, 2024
Share-Based Payment Arrangement [Abstract]
Restricted Stock Unit Activity	A summary of the Company’s RSU activity and related information for the nine months ended June 29, 2024 is as follows: Number of RSUs (in thousands) Weighted-Average Aggregate Fair Value (in millions) Balance as of September 30, 2023 180,247 $ 135.91 RSUs granted 78,276 $ 172.26 RSUs vested (83,842) $ 126.47 RSUs canceled (8,258) $ 137.85 Balance as of June 29, 2024 166,423 $ 157.66 $ 35,052
Summary of Share-Based Compensation Expense and the Related Income Tax Benefit	The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Share-based compensation expense $ 2,869 $ 2,617 $ 8,830 $ 8,208 Income tax benefit related to share-based compensation expense $ (764) $ (993) $ (2,662) $ (2,791)

Segment Information and Geogr_2

Segment Information and Geographic Data (Tables)	9 Months Ended
	Jun. 29, 2024
Segment Reporting [Abstract]
Information by Reportable Segment	The following table shows information by reportable segment for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Americas: Net sales $ 37,678 $ 35,383 $ 125,381 $ 122,445 Operating income $ 15,209 $ 13,117 $ 50,640 $ 44,908 Europe: Net sales $ 21,884 $ 20,205 $ 76,404 $ 71,831 Operating income $ 9,170 $ 7,995 $ 31,872 $ 27,380 Greater China: Net sales $ 14,728 $ 15,758 $ 51,919 $ 57,475 Operating income $ 5,562 $ 6,207 $ 20,884 $ 24,175 Japan: Net sales $ 5,097 $ 4,821 $ 19,126 $ 18,752 Operating income $ 2,544 $ 2,443 $ 9,498 $ 9,073 Rest of Asia Pacific: Net sales $ 6,390 $ 5,630 $ 23,275 $ 23,284 Operating income $ 2,610 $ 2,328 $ 9,995 $ 9,447
Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations	A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2024 and July 1, 2023 is as follows (in millions): Three Months Ended Nine Months Ended June 29, July 1, June 29, July 1, Segment operating income $ 35,095 $ 32,090 $ 122,889 $ 114,983 Research and development expense (8,006) (7,442) (23,605) (22,608) Other corporate expenses, net (1,737) (1,650) (5,659) (5,043) Total operating income $ 25,352 $ 22,998 $ 93,625 $ 87,332

Revenue - Net Sales Disaggregat

Revenue - Net Sales Disaggregated by Significant Products and Services (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Disaggregation of Revenue [Line Items]
Net sales	$ 85,777	$ 81,797	$ 296,105	$ 293,787
iPhone
Disaggregation of Revenue [Line Items]
Net sales	39,296	39,669	154,961	156,778
Mac
Disaggregation of Revenue [Line Items]
Net sales	7,009	6,840	22,240	21,743
iPad
Disaggregation of Revenue [Line Items]
Net sales	7,162	5,791	19,744	21,857
Wearables, Home and Accessories
Disaggregation of Revenue [Line Items]
Net sales	8,097	8,284	27,963	30,523
Services
Disaggregation of Revenue [Line Items]
Net sales	$ 24,213	$ 21,213	$ 71,197	$ 62,886

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Billions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue recognized that was included in deferred revenue at the beginning of the period	$ 3.4	$ 3.3	$ 6.5	$ 7
Total deferred revenue	$ 12.5		$ 12.5		$ 12.1

Revenue - Deferred Revenue, Exp

Revenue - Deferred Revenue, Expected Timing of Realization (Details)	Jun. 29, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-06-30
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	64%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-06-29
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	25%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-06-28
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	9%
Deferred revenue, expected timing of realization, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-06-27
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue, expected timing of realization, percentage	2%
Deferred revenue, expected timing of realization, period	1 year

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Numerator:
Net income	$ 21,448	$ 19,881	$ 79,000	$ 74,039
Denominator:
Weighted-average basic shares outstanding (in shares)	15,287,521	15,697,614	15,401,047	15,792,497
Effect of dilutive share-based awards (in shares)	60,654	77,407	62,128	66,766
Weighted-average diluted shares (in shares)	15,348,175	15,775,021	15,463,175	15,859,263
Basic earnings per share (in dollars per share)	$ 1.40	$ 1.27	$ 5.13	$ 4.69
Diluted earnings per share (in dollars per share)	$ 1.40	$ 1.26	$ 5.11	$ 4.67

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) shares in Millions	9 Months Ended
	Jul. 01, 2023 shares
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Restricted stock units excluded from the computation of diluted earnings per share because their effect would have been antidilutive (in shares)	32

Financial Instruments - Cash, C

Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($) $ in Millions	Jun. 29, 2024	Sep. 30, 2023
Marketable Securities [Line Items]
Cash, Cash Equivalents and Marketable Securities, Adjusted Cost	$ 160,230	$ 173,752
Cash Equivalents and Marketable Securities, Unrealized Gains	220	30
Cash Equivalents and Marketable Securities, Unrealized Losses	(7,409)	(11,683)
Cash, Cash Equivalents and Marketable Securities, Fair Value	153,041	162,099
Cash and Cash Equivalents	25,565	29,965
Current Marketable Securities	36,236	31,590
Non-Current Marketable Securities	91,240	100,544
Total marketable securities that were restricted from general use	14,100	13,800
Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	2,141	923
Marketable Securities, Equity, Unrealized Gains	76	12
Marketable Securities, Equity, Unrealized Losses	(7)	(26)
Marketable Securities, Equity, Fair Value	2,210	909
Cash and Cash Equivalents	1,648	481
Current Marketable Securities	562	428
Non-Current Marketable Securities	0	0
Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	135,223	144,470
Marketable Securities, Debt, Unrealized Gains	144	18
Marketable Securities, Debt, Unrealized Losses	(7,402)	(11,657)
Marketable Securities, Debt, Fair Value	127,965	132,831
Cash and Cash Equivalents	1,051	1,125
Current Marketable Securities	35,674	31,162
Non-Current Marketable Securities	91,240	100,544
Cash
Marketable Securities [Line Items]
Cash	22,866	28,359
Cash and Cash Equivalents	22,866	28,359
Current Marketable Securities	0	0
Non-Current Marketable Securities	0	0
Money market funds | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	1,648	481
Marketable Securities, Equity, Unrealized Gains	0	0
Marketable Securities, Equity, Unrealized Losses	0	0
Marketable Securities, Equity, Fair Value	1,648	481
Cash and Cash Equivalents	1,648	481
Current Marketable Securities	0	0
Non-Current Marketable Securities	0	0
Mutual funds | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost	493
Marketable Securities, Equity, Unrealized Gains	76
Marketable Securities, Equity, Unrealized Losses	(7)
Marketable Securities, Equity, Fair Value	562
Cash and Cash Equivalents	0
Current Marketable Securities	562
Non-Current Marketable Securities	0
Mutual funds and equity securities | Level 1
Marketable Securities [Line Items]
Marketable Securities, Equity, Adjusted Cost		442
Marketable Securities, Equity, Unrealized Gains		12
Marketable Securities, Equity, Unrealized Losses		(26)
Marketable Securities, Equity, Fair Value		428
Cash and Cash Equivalents		0
Current Marketable Securities		428
Non-Current Marketable Securities		0
U.S. Treasury securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	16,298	19,406
Marketable Securities, Debt, Unrealized Gains	3	0
Marketable Securities, Debt, Unrealized Losses	(855)	(1,292)
Marketable Securities, Debt, Fair Value	15,446	18,114
Cash and Cash Equivalents	138	35
Current Marketable Securities	4,649	5,468
Non-Current Marketable Securities	10,659	12,611
U.S. agency securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	5,500	5,736
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(418)	(600)
Marketable Securities, Debt, Fair Value	5,082	5,136
Cash and Cash Equivalents	73	36
Current Marketable Securities	518	271
Non-Current Marketable Securities	4,491	4,829
Non-U.S. government securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	17,560	17,533
Marketable Securities, Debt, Unrealized Gains	31	6
Marketable Securities, Debt, Unrealized Losses	(680)	(1,048)
Marketable Securities, Debt, Fair Value	16,911	16,491
Cash and Cash Equivalents	0	0
Current Marketable Securities	11,592	11,332
Non-Current Marketable Securities	5,319	5,159
Certificates of deposit and time deposits | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	1,337	1,354
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	0	0
Marketable Securities, Debt, Fair Value	1,337	1,354
Cash and Cash Equivalents	838	1,034
Current Marketable Securities	492	320
Non-Current Marketable Securities	7	0
Commercial paper | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	1,346	608
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	0	0
Marketable Securities, Debt, Fair Value	1,346	608
Cash and Cash Equivalents	2	0
Current Marketable Securities	1,344	608
Non-Current Marketable Securities	0	0
Corporate debt securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	68,194	76,840
Marketable Securities, Debt, Unrealized Gains	83	6
Marketable Securities, Debt, Unrealized Losses	(3,350)	(5,956)
Marketable Securities, Debt, Fair Value	64,927	70,890
Cash and Cash Equivalents	0	20
Current Marketable Securities	15,489	12,627
Non-Current Marketable Securities	49,438	58,243
Municipal securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	480	628
Marketable Securities, Debt, Unrealized Gains	0	0
Marketable Securities, Debt, Unrealized Losses	(13)	(26)
Marketable Securities, Debt, Fair Value	467	602
Cash and Cash Equivalents	0	0
Current Marketable Securities	197	192
Non-Current Marketable Securities	270	410
Mortgage- and asset-backed securities | Level 2
Marketable Securities [Line Items]
Marketable Securities, Debt, Adjusted Cost	24,508	22,365
Marketable Securities, Debt, Unrealized Gains	27	6
Marketable Securities, Debt, Unrealized Losses	(2,086)	(2,735)
Marketable Securities, Debt, Fair Value	22,449	19,636
Cash and Cash Equivalents	0	0
Current Marketable Securities	1,393	344
Non-Current Marketable Securities	$ 21,056	$ 19,292

Financial Instruments - Non-Cur

Financial Instruments - Non-Current Marketable Debt Securities by Contractual Maturity (Details) $ in Millions	Jun. 29, 2024 USD ($)
Fair value of non-current marketable debt securities by contractual maturity
Due after 1 year through 5 years	$ 64,209
Due after 5 years through 10 years	8,660
Due after 10 years	18,371
Total fair value	$ 91,240

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) - Vendor	9 Months Ended	12 Months Ended
	Jun. 29, 2024	Sep. 30, 2023
Trade receivables | Credit concentration risk | Cellular network carriers
Financial Instruments [Line Items]
Concentration risk, percentage	32%	41%
Non-trade receivables | Credit concentration risk
Financial Instruments [Line Items]
Number of vendors that individually represented 10% or more of total vendor non-trade receivables	2	2
Non-trade receivables | Credit concentration risk | Vendor one
Financial Instruments [Line Items]
Concentration risk, percentage	46%	48%
Non-trade receivables | Credit concentration risk | Vendor two
Financial Instruments [Line Items]
Concentration risk, percentage	18%	23%
Hedges of foreign currency exposure associated with revenue and inventory purchases
Financial Instruments [Line Items]
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions	12 months
Hedges of foreign currency exposure associated with term debt
Financial Instruments [Line Items]
Maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for foreign currency transactions	18 years

Financial Instruments - Notiona

Financial Instruments - Notional Amounts of Derivative Instruments (Details) - USD ($) $ in Millions	Jun. 29, 2024	Sep. 30, 2023
Derivatives designated as accounting hedges | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	$ 65,542	$ 74,730
Derivatives designated as accounting hedges | Interest rate contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	13,875	19,375
Derivatives not designated as accounting hedges | Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivatives, notional amount	$ 97,136	$ 104,777

Financial Instruments - Derivat

Financial Instruments - Derivative Instruments Designated as Fair Value Hedges and Related Hedged Items (Details) - USD ($) $ in Millions	Jun. 29, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Carrying amount of hedged marketable securities	$ 15,007	$ 14,433
Hedged asset, statement of financial position [Extensible Enumeration]	Marketable securities, Marketable securities	Marketable securities, Marketable securities
Carrying amount of hedged term debt	$ (13,096)	$ (18,247)
Hedged liability, statement of financial position [Extensible Enumeration]	Term debt, Term debt	Term debt, Term debt

Condensed Consolidated Financ_3

Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Jun. 29, 2024	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gross property, plant and equipment	$ 117,129	$ 114,599
Accumulated depreciation	(72,627)	(70,884)
Total property, plant and equipment, net	$ 44,502	$ 43,715

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	Aug. 30, 2016 Subsidiary
Unfavorable investigation outcome, EU State Aid rules
Income Tax Contingency [Line Items]
Number of subsidiaries impacted by the European Commission tax ruling	2

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($) $ in Millions	Jun. 29, 2024	Sep. 30, 2023
Debt Instrument [Line Items]
Commercial paper	$ 2,994	$ 5,985
Fixed-rate notes, aggregate carrying amount	98,300	105,100
Commercial paper
Debt Instrument [Line Items]
Commercial paper	3,000	6,000
Level 2
Debt Instrument [Line Items]
Fixed-rate notes, aggregate fair value	$ 86,200	$ 90,800

Debt - Summary of Cash Flows As

Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023
Maturities 90 days or less:
Repayments of commercial paper, net	$ (2,985)	$ (3,326)
Maturities greater than 90 days:
Repayments of commercial paper	0	(2,645)
Total repayments of commercial paper, net	$ (2,985)	$ (5,971)

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) shares in Millions, $ in Billions	9 Months Ended
	Jun. 29, 2024 USD ($) shares
Stockholders' Equity Note [Abstract]
Number of shares repurchased (in shares) | shares	387
Amount of share repurchases | $	$ 70

Share-Based Compensation - Rest

Share-Based Compensation - Restricted Stock Unit Activity and Related Information (Details) - Restricted stock units $ / shares in Units, shares in Thousands, $ in Millions	9 Months Ended
	Jun. 29, 2024 USD ($) $ / shares shares
Number of Restricted Stock Units
Beginning balance (in shares) | shares	180,247
RSUs granted (in shares) | shares	78,276
RSUs vested (in shares) | shares	(83,842)
RSUs canceled (in shares) | shares	(8,258)
Ending balance (in shares) | shares	166,423
Weighted-Average Grant Date Fair Value Per RSU
Beginning balance (in dollars per share) | $ / shares	$ 135.91
RSUs granted (in dollars per share) | $ / shares	172.26
RSUs vested (in dollars per share) | $ / shares	126.47
RSUs canceled (in dollars per share) | $ / shares	137.85
Ending balance (in dollars per share) | $ / shares	$ 157.66
Aggregate Fair Value
Aggregate fair value of RSUs | $	$ 35,052

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - Restricted stock units - USD ($) $ in Billions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of RSUs as of the respective vesting dates	$ 6.4	$ 7	$ 15	$ 14.9
Total unrecognized compensation cost related to RSUs	$ 21.9		$ 21.9
Total unrecognized compensation cost related to RSUs, weighted-average recognition period			2 years 7 months 6 days

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Share-Based Payment Arrangement [Abstract]
Share-based compensation expense	$ 2,869	$ 2,617	$ 8,830	$ 8,208
Income tax benefit related to share-based compensation expense	$ (764)	$ (993)	$ (2,662)	$ (2,791)

Segment Information and Geogr_3

Segment Information and Geographic Data - Information by Reportable Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Segment Reporting Information [Line Items]
Net sales	$ 85,777	$ 81,797	$ 296,105	$ 293,787
Operating income	25,352	22,998	93,625	87,332
Americas
Segment Reporting Information [Line Items]
Net sales	37,678	35,383	125,381	122,445
Operating income	15,209	13,117	50,640	44,908
Europe
Segment Reporting Information [Line Items]
Net sales	21,884	20,205	76,404	71,831
Operating income	9,170	7,995	31,872	27,380
Greater China
Segment Reporting Information [Line Items]
Net sales	14,728	15,758	51,919	57,475
Operating income	5,562	6,207	20,884	24,175
Japan
Segment Reporting Information [Line Items]
Net sales	5,097	4,821	19,126	18,752
Operating income	2,544	2,443	9,498	9,073
Rest of Asia Pacific
Segment Reporting Information [Line Items]
Net sales	6,390	5,630	23,275	23,284
Operating income	$ 2,610	$ 2,328	$ 9,995	$ 9,447

Segment Information and Geogr_4

Segment Information and Geographic Data - Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	$ 25,352	$ 22,998	$ 93,625	$ 87,332
Research and development expense	(8,006)	(7,442)	(23,605)	(22,608)
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating income	35,095	32,090	122,889	114,983
Segment reconciling items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Research and development expense	(8,006)	(7,442)	(23,605)	(22,608)
Corporate non-segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Other corporate expenses, net	$ (1,737)	$ (1,650)	$ (5,659)	$ (5,043)